Omadacycline vs. Moxifloxacin for the Treatment of Community-Acquired Bacterial Pneumonia
Condition(s):Community-acquired Pneumonia; Bacterial PneumoniaLast Updated:March 15, 2024Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Community-acquired Pneumonia; Bacterial PneumoniaLast Updated:March 15, 2024Active, not recruiting
Condition(s):Liver AbscessLast Updated:December 2, 2015Completed
Condition(s):Chronic PeriodontitisLast Updated:May 12, 2010Completed
Condition(s):CataractLast Updated:August 22, 2023Completed
Condition(s):TBLast Updated:November 27, 2012Terminated
Condition(s):CataractsLast Updated:December 22, 2020Completed
Condition(s):CholangitisLast Updated:February 24, 2016Completed
Condition(s):Advanced Breast Cancer; Antibiotic; Stable Disease With a Trend of ProgressionLast Updated:November 16, 2018Completed
Condition(s):Helicobacter Pylori Infection; Helicobacter Pylori Infection, Susceptibility toLast Updated:May 18, 2023Completed
Condition(s):Endophthalmitis; Macula Edema; CataractLast Updated:November 3, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.